검 색
Interview
Articles
Industry
Info
기사 목록
1st Inaugural KUMA Conference
May - August 2014
The Unrealized Potential of Stem Cell Therapy
Novartis’ LCZ696 for CHF draws approval optimism after meeting difficult Phase III endpoints – experts
Celgene’s Revlimid has experts optimistic about potential in Phase III non-del (5q) MDS trial in transfusion-dependent patients
Laboratory Payments to Referring Physicians
Dr. Kyoung-Ryul Lee, Hanaro Medical Foundation
INSPIRATIONAL KOREAN HEALTHCARE LEADER “Congressman Chung Ui-Hwa’s Journey from Medicine to the National Assembly”
WKMO 3rd Annual Convention
WKMO Executives Official Visit to Korea
12
/ 15
12 / 15
